Biologic Drugs Market Size, Type Analysis, Application Analysis, End-Use, Industry Analysis, Regional Outlook, Competitive Strategies And Forecasts, 2023-2032

  • Report ID: ME_0063072
  • Format: Electronic (PDF)
  • Publish Type:
  • Number of Pages: 250
Home Healthcare biologic drugs market....
  • Single User $3500
  • Multi User $4500
  • Enterprise User $5500

Market Snapshot

CAGR:9.47
2023
2032

Source: Market Expertz

RND-Favicon
Study Period 2019-2032
Base Year 2023
Forcast Year 2023-2032
CAGR 9.47
Healthcare-companies
Healthcare-Snapshot

Gain accurate insights regarding the negative impacts of COVID-19 on all markets and industries

Download Sample Pdf
Download Sample Pdf

Report Overview

The global Biologic Drugs market is valued at million US$ in 2019 and will reach million US$ by the end of 2026, growing at a CAGR of during 2019-2026. The objectives of this study are to define, segment, and project the size of the Biologic Drugs market based on company, product type, end user and key regions.

This report studies the global market size of Biologic Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Biologic Drugs in these regions.
This research report categorizes the global Biologic Drugs market by top players/brands, region, type and end user. This report also studies the global Biologic Drugs market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Roche
Abbott Laboratories
Johnson & Johnson
Merck & Co.
Pfizer
Amgen
Sanofi
Novartis
Eli Lilly
Amgen

Market size by Product
Humira
Remicade
Rituxan
Enbrel
Lantus
Avastin
Herceptin
Others
Market size by End User
Diabetes
Inflammation
Auto-Immune Diseases
Blood Diseases
Cardiovascular Diseases
Others

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Biologic Drugs market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2019, and forecast to 2026.
To understand the structure of Biologic Drugs market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Biologic Drugs companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Biologic Drugs submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Biologic Drugs are as follows:
History Year: 2014-2019
Base Year: 2019
Estimated Year: 2019
Forecast Year 2019 to 2026

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Biologic Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents

1 Study Coverage
1.1 Biologic Drugs Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Biologic Drugs Market Size Growth Rate by Product
1.4.2 Humira
1.4.3 Remicade
1.4.4 Rituxan
1.4.5 Enbrel
1.4.6 Lantus
1.4.7 Avastin
1.4.8 Herceptin
1.4.9 Others
1.5 Market by End User
1.5.1 Global Biologic Drugs Market Size Growth Rate by End User
1.5.2 Diabetes
1.5.3 Inflammation
1.5.4 Auto-Immune Diseases
1.5.5 Blood Diseases
1.5.6 Cardiovascular Diseases
1.5.7 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Biologic Drugs Market Size
2.1.1 Global Biologic Drugs Revenue 2014-2025
2.1.2 Global Biologic Drugs Sales 2014-2025
2.2 Biologic Drugs Growth Rate by Regions
2.2.1 Global Biologic Drugs Sales by Regions
2.2.2 Global Biologic Drugs Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Biologic Drugs Sales by Manufacturers
3.1.1 Biologic Drugs Sales by Manufacturers
3.1.2 Biologic Drugs Sales Market Share by Manufacturers
3.1.3 Global Biologic Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Biologic Drugs Revenue by Manufacturers
3.2.1 Biologic Drugs Revenue by Manufacturers (2014-2019)
3.2.2 Biologic Drugs Revenue Share by Manufacturers (2014-2019)
3.3 Biologic Drugs Price by Manufacturers
3.4 Biologic Drugs Manufacturing Base Distribution, Product Types
3.4.1 Biologic Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Biologic Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Biologic Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global Biologic Drugs Sales by Product
4.2 Global Biologic Drugs Revenue by Product
4.3 Biologic Drugs Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global Biologic Drugs Breakdown Data by End User

6 North America
6.1 North America Biologic Drugs by Countries
6.1.1 North America Biologic Drugs Sales by Countries
6.1.2 North America Biologic Drugs Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Biologic Drugs by Product
6.3 North America Biologic Drugs by End User

7 Europe
7.1 Europe Biologic Drugs by Countries
7.1.1 Europe Biologic Drugs Sales by Countries
7.1.2 Europe Biologic Drugs Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Biologic Drugs by Product
7.3 Europe Biologic Drugs by End User

8 Asia Pacific
8.1 Asia Pacific Biologic Drugs by Countries
8.1.1 Asia Pacific Biologic Drugs Sales by Countries
8.1.2 Asia Pacific Biologic Drugs Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Biologic Drugs by Product
8.3 Asia Pacific Biologic Drugs by End User

9 Central & South America
9.1 Central & South America Biologic Drugs by Countries
9.1.1 Central & South America Biologic Drugs Sales by Countries
9.1.2 Central & South America Biologic Drugs Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Biologic Drugs by Product
9.3 Central & South America Biologic Drugs by End User

10 Middle East and Africa
10.1 Middle East and Africa Biologic Drugs by Countries
10.1.1 Middle East and Africa Biologic Drugs Sales by Countries
10.1.2 Middle East and Africa Biologic Drugs Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Biologic Drugs by Product
10.3 Middle East and Africa Biologic Drugs by End User

11 Company Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Company Business Overview
11.1.3 Roche Biologic Drugs Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Roche Biologic Drugs Products Offered
11.1.5 Roche Recent Development
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Details
11.2.2 Company Business Overview
11.2.3 Abbott Laboratories Biologic Drugs Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Abbott Laboratories Biologic Drugs Products Offered
11.2.5 Abbott Laboratories Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Details
11.3.2 Company Business Overview
11.3.3 Johnson & Johnson Biologic Drugs Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Johnson & Johnson Biologic Drugs Products Offered
11.3.5 Johnson & Johnson Recent Development
11.4 Merck & Co.
11.4.1 Merck & Co. Company Details
11.4.2 Company Business Overview
11.4.3 Merck & Co. Biologic Drugs Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Merck & Co. Biologic Drugs Products Offered
11.4.5 Merck & Co. Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Company Business Overview
11.5.3 Pfizer Biologic Drugs Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Pfizer Biologic Drugs Products Offered
11.5.5 Pfizer Recent Development
11.6 Amgen
11.6.1 Amgen Company Details
11.6.2 Company Business Overview
11.6.3 Amgen Biologic Drugs Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Amgen Biologic Drugs Products Offered
11.6.5 Amgen Recent Development
11.7 Sanofi
11.7.1 Sanofi Company Details
11.7.2 Company Business Overview
11.7.3 Sanofi Biologic Drugs Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Sanofi Biologic Drugs Products Offered
11.7.5 Sanofi Recent Development
11.8 Novartis
11.8.1 Novartis Company Details
11.8.2 Company Business Overview
11.8.3 Novartis Biologic Drugs Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Novartis Biologic Drugs Products Offered
11.8.5 Novartis Recent Development
11.9 Eli Lilly
11.9.1 Eli Lilly Company Details
11.9.2 Company Business Overview
11.9.3 Eli Lilly Biologic Drugs Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Eli Lilly Biologic Drugs Products Offered
11.9.5 Eli Lilly Recent Development
11.10 Amgen
11.10.1 Amgen Company Details
11.10.2 Company Business Overview
11.10.3 Amgen Biologic Drugs Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Amgen Biologic Drugs Products Offered
11.10.5 Amgen Recent Development

12 Future Forecast
12.1 Biologic Drugs Market Forecast by Regions
12.1.1 Global Biologic Drugs Sales Forecast by Regions 2019-2025
12.1.2 Global Biologic Drugs Revenue Forecast by Regions 2019-2025
12.2 Biologic Drugs Market Forecast by Product
12.2.1 Global Biologic Drugs Sales Forecast by Product 2019-2025
12.2.2 Global Biologic Drugs Revenue Forecast by Product 2019-2025
12.3 Biologic Drugs Market Forecast by End User
12.4 North America Biologic Drugs Forecast
12.5 Europe Biologic Drugs Forecast
12.6 Asia Pacific Biologic Drugs Forecast
12.7 Central & South America Biologic Drugs Forecast
12.8 Middle East and Africa Biologic Drugs Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Biologic Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer


List of Tables and Figures

Figure Biologic Drugs Product Picture
Table Biologic Drugs Market Segments
Table Key Manufacturers Biologic Drugs Covered
Table Global Biologic Drugs Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Biologic Drugs Sales Market Share by Product 2014-2025
Figure Humira Product Picture
Table Major Manufacturers of Humira
Figure Remicade Product Picture
Table Major Manufacturers of Remicade
Figure Rituxan Product Picture
Table Major Manufacturers of Rituxan
Figure Enbrel Product Picture
Table Major Manufacturers of Enbrel
Figure Lantus Product Picture
Table Major Manufacturers of Lantus
Figure Avastin Product Picture
Table Major Manufacturers of Avastin
Figure Herceptin Product Picture
Table Major Manufacturers of Herceptin
Figure Others Product Picture
Table Major Manufacturers of Others
Table Global Biologic Drugs Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Diabetes
Figure Inflammation
Figure Auto-Immune Diseases
Figure Blood Diseases
Figure Cardiovascular Diseases
Figure Others
Figure Biologic Drugs Report Years Considered
Figure Global Biologic Drugs Market Size 2014-2025 (Million US$)
Figure Global Biologic Drugs Sales 2014-2025 (K Units)
Table Global Biologic Drugs Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Biologic Drugs Sales by Regions 2014-2019 (K Units)
Table Global Biologic Drugs Sales Market Share by Regions 2014-2019
Figure Global Biologic Drugs Sales Market Share by Regions 2014-2019
Figure 2018 Global Biologic Drugs Sales Market Share by Regions
Table Global Biologic Drugs Revenue by Regions 2014-2019 (Million US$)
Table Global Biologic Drugs Revenue Market Share by Regions 2014-2019
Figure Global Biologic Drugs Revenue Market Share by Regions 2014-2019
Figure 2018 Global Biologic Drugs Revenue Market Share by Regions
Table Global Biologic Drugs Sales by Manufacturers (2014-2019) (K Units)
Table Global Biologic Drugs Sales Share by Manufacturers (2014-2019)
Figure Global Biologic Drugs Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Biologic Drugs Revenue by Manufacturers (2014-2019) (Million USD)
Table Biologic Drugs Revenue Share by Manufacturers (2014-2019)
Figure Biologic Drugs Value Share by Manufacturers in 2018
Table Key Manufacturers Biologic Drugs Price (2014-2019) (USD/Unit)
Table Biologic Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Biologic Drugs Product Type
Table Date of International Manufacturers Enter into Biologic Drugs Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Biologic Drugs Sales by Product (2014-2019) (K Units)
Table Global Biologic Drugs Sales Share by Product (2014-2019)
Figure Global Biologic Drugs Sales Market Share by Product (2014-2019)
Figure Global Biologic Drugs Sales Market Share by Product in 2018
Table Global Biologic Drugs Revenue by Product (2014-2019) (Million US$)
Table Global Biologic Drugs Revenue Share by Product (2014-2019)
Figure Global Biologic Drugs Revenue Market Share by Product (2014-2019)
Figure Global Biologic Drugs Revenue Market Share by Product in 2018
Table Biologic Drugs Price by Product 2014-2019 (USD/Unit)
Table Global Biologic Drugs Sales by End User (2014-2019) (K Units)
Table Global Biologic Drugs Sales Share by End User (2014-2019)
Figure Global Sales Biologic Drugs Market Share by End User (2014-2019)
Figure Global Sales Biologic Drugs Market Share by End User in 2018
Figure North America Biologic Drugs Sales Growth Rate 2014-2019 (K Units)
Figure North America Biologic Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table North America Biologic Drugs Sales by Countries (2014-2019) (K Units)
Table North America Biologic Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 North America Biologic Drugs Sales Market Share by Countries
Table North America Biologic Drugs Revenue by Countries (2014-2019) (Million US$)
Table North America Biologic Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Biologic Drugs Revenue Market Share by Countries
Figure United States Biologic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure United States Biologic Drugs Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Biologic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Canada Biologic Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Biologic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Biologic Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table North America Biologic Drugs Sales by Product (2014-2019) (K Units)
Table North America Biologic Drugs Sales Market Share by Product (2014-2019)
Figure 2018 North America Biologic Drugs Market Share by Product
Table North America Biologic Drugs Sales by End User (2014-2019) (K Units)
Table North America Biologic Drugs Sales Market Share by End User (2014-2019)
Figure 2018 North America Biologic Drugs Market Share by End User
Figure Europe Biologic Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Europe Biologic Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Biologic Drugs Sales by Countries (2014-2019) (K Units)
Table Europe Biologic Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Biologic Drugs Sales Market Share by Countries
Table Europe Biologic Drugs Revenue by Countries (2014-2019) (Million US$)
Table Europe Biologic Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Biologic Drugs Revenue Market Share by Countries
Figure Germany Biologic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Germany Biologic Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure France Biologic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure France Biologic Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Biologic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure UK Biologic Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Biologic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Italy Biologic Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Biologic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Russia Biologic Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Biologic Drugs Sales by Product (2014-2019) (K Units)
Table Europe Biologic Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Europe Biologic Drugs Market Share by Product
Table Europe Biologic Drugs Sales by End User (2014-2019) (K Units)
Table Europe Biologic Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Europe Biologic Drugs Market Share by End User
Figure Asia Pacific Biologic Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Biologic Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Biologic Drugs Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Biologic Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Biologic Drugs Sales Market Share by Countries
Table Asia Pacific Biologic Drugs Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Biologic Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Biologic Drugs Revenue Market Share by Countries
Figure China Biologic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure China Biologic Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Biologic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Japan Biologic Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Biologic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Korea Biologic Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure India Biologic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure India Biologic Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Biologic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Australia Biologic Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Biologic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Biologic Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Biologic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Biologic Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Biologic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Biologic Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Biologic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Biologic Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Biologic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Biologic Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Biologic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Biologic Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Biologic Drugs Sales by Product (2014-2019) (K Units)
Table Asia Pacific Biologic Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Biologic Drugs Market Share by Product
Table Asia Pacific Biologic Drugs Sales by End User (2014-2019) (K Units)
Table Asia Pacific Biologic Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Biologic Drugs Market Share by End User
Figure Central & South America Biologic Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Biologic Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Biologic Drugs Sales by Countries (2014-2019) (K Units)
Table Central & South America Biologic Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Biologic Drugs Sales Market Share by Countries
Table Central & South America Biologic Drugs Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Biologic Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Biologic Drugs Revenue Market Share by Countries
Figure Brazil Biologic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Biologic Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Biologic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Biologic Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Biologic Drugs Sales by Product (2014-2019) (K Units)
Table Central & South America Biologic Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Biologic Drugs Market Share by Product
Table Central & South America Biologic Drugs Sales by End User (2014-2019) (K Units)
Table Central & South America Biologic Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Biologic Drugs Market Share by End User
Figure Middle East and Africa Biologic Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Biologic Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Biologic Drugs Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Biologic Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Biologic Drugs Sales Market Share by Countries
Table Middle East and Africa Biologic Drugs Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Biologic Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Biologic Drugs Revenue Market Share by Countries
Figure GCC Countries Biologic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Biologic Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Biologic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Biologic Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Biologic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Biologic Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Biologic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Biologic Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Biologic Drugs Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Biologic Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Biologic Drugs Market Share by Product
Table Middle East and Africa Biologic Drugs Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Biologic Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Biologic Drugs Market Share by End User
Table Roche Company Details
Table Roche Biologic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Roche Recent Development

Table Abbott Laboratories Company Details
Table Abbott Laboratories Biologic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Abbott Laboratories Recent Development

Table Johnson & Johnson Company Details
Table Johnson & Johnson Biologic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Johnson & Johnson Recent Development

Table Merck & Co. Company Details
Table Merck & Co. Biologic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Merck & Co. Recent Development

Table Pfizer Company Details
Table Pfizer Biologic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Pfizer Recent Development

Table Amgen Company Details
Table Amgen Biologic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Amgen Recent Development

Table Sanofi Company Details
Table Sanofi Biologic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Sanofi Recent Development

Table Novartis Company Details
Table Novartis Biologic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Novartis Recent Development

Table Eli Lilly Company Details
Table Eli Lilly Biologic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Eli Lilly Recent Development

Table Amgen Company Details
Table Amgen Biologic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Amgen Recent Development

Table Global Biologic Drugs Sales Forecast by Regions 2019-2025 (K Units)
Table Global Biologic Drugs Sales Market Share Forecast by Regions 2019-2025
Table Global Biologic Drugs Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Biologic Drugs Revenue Market Share Forecast by Regions 2019-2025
Table Global Biologic Drugs Sales Forecast by Product 2019-2025 (K Units)
Table Global Biologic Drugs Sales Market Share Forecast by Product 2019-2025
Table Global Biologic Drugs Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Biologic Drugs Revenue Market Share Forecast by Product 2019-2025
Table Global Biologic Drugs Sales Forecast by End User 2019-2025 (K Units)
Table Global Biologic Drugs Sales Market Share Forecast by End User 2019-2025
Figure North America Biologic Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Biologic Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Biologic Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Biologic Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Biologic Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Biologic Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Biologic Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Biologic Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Biologic Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Biologic Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Biologic Drugs Value Chain
Table Biologic Drugs Customers List
Table Biologic Drugs Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

RESEARCH METHODOLOGY

A research methodology is a systematic approach for assessing or conducting a market study. Researchers tend to draw on a variety of both qualitative and quantitative study methods, inclusive of investigations, survey, secondary data and market observation.

Such plans can focus on classifying the products offered by leading market players or simply use statistical models to interpret observations or test hypotheses. While some methods aim for a detailed description of the factors behind an observation, others present the context of the current market scenario.

Now letā€™s take a closer look at the research methods here.

Secondary Research Model

Extensive data is obtained and cumulated on a substantial basis during the inception phase of the research process. The data accumulated is consistently filtered through validation from the in-house database, paid sources as well reputable industry magazines. A robust research study requires an understanding of the overall value chain. Annual reports and financials of industry players are studied thoroughly to have a comprehensive idea of the market taxonomy.

Primary Insights

Post conglomeration of the data obtained through secondary research; a validation process is initiated to verify the numbers or figures. This process is usually performed by having a detailed discussion with the industry experts.

However, we do not restrict our primary interviews only to the industry leaders. Our team covers the entire value chain while verifying the data. A significant number of raw material suppliers, local manufacturers, distributors, and stakeholders are interviewed to make our findings authentic. The current trends which include the drivers, restraints, and opportunities are also derived through the primary research process.

Market Estimation

The market estimation is conducted by analyzing the data collected through both secondary and primary research. This process involves market breakdown, bottom-up and top- down approach.

Moreover, while forecasting the market a comprehensive statistical time series model is designed for each market. Macroeconomic indicators are considered to understand the current trends of the market. Each data point is verified by the process of data triangulation method to arrive at the final market estimates.

Final Presentation

The penultimate process results in a holistic research report. The study equips key industry players to undertake significant strategic decisions through the findings. The report encompasses detailed market information. Graphical representations of the current market trends are also made available in order to make the study highly comprehensible for the reader.

You can also purchase parts of this report. Do you want to check out a section wise price list?

Personalized Business Report Tailored to Your Requirements

  • Our expert analysts collaborate directly with you to comprehend your specific needs.
  • Get data on regions, segments, competitors, and vendors of your choice.
  • Information is presented in alignment with your exact preferences and formatting.
Free Sample Report

"Find new revenue generation opportunities"